Cushing Syndrome: A Review.
Reincke M, Fleseriu M.
JAMA. 2023 Jul 11;330(2):170-181. doi: 10.1001/jama.2023.11305.
Primary aldosteronism - a multidimensional syndrome.
Turcu AF, Yang J, Vaidya A.
Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31.
Primary Aldosteronism: JACC State-of-the-Art Review.
Rossi GP.
J Am Coll Cardiol. 2019 Dec 3;74(22):2799-2811. doi: 10.1016/j.jacc.2019.09.057.
Primary Aldosteronism: Practical Approach to Diagnosis and Management.
Byrd JB, Turcu AF, Auchus RJ.
Circulation. 2018 Aug 21;138(8):823-835. doi: 10.1161/CIRCULATIONAHA.118.033597.
Subclinical hypercortisolism in adrenal incidentaloma.
Debono M, Newell-Price J.
Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):185-92. doi: 10.1097/MED.0000000000000151.
Surgical Approach to Endocrine Hypertension in Patients with Adrenal Disorders.
Shank J, Prescott JD, Mathur A.
Endocrinol Metab Clin North Am. 2019 Dec;48(4):875-885. doi: 10.1016/j.ecl.2019.08.014. Epub 2019 Sep 25.
Adrenal Imaging in Patients with Endocrine Hypertension.
Delivanis DA, Vassiliadi DA, Tsagarakis S.
Endocrinol Metab Clin North Am. 2019 Dec;48(4):667-680. doi: 10.1016/j.ecl.2019.08.001. Epub 2019 Sep 17.
Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey.
Di Dalmazi G, Goi J, Burrello J, Tucci L, Cicero AFG, Mancusi C, Coletti Moia E, Iaccarino G, Borghi C, Muiesan ML, Ferri C, Mulatero P.
J Endocrinol Invest. 2024 Dec;47(12):3029-3038. doi: 10.1007/s40618-024-02387-2. Epub 2024 Jun 24.
Pathophysiology of adrenal hypertension.
Moneva MH, Gomez-Sanchez CE.
Semin Nephrol. 2002 Jan;22(1):44-53.
Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma.
Oki K, Yamane K, Nakanishi S, Shiwa T, Kohno N.
Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):244-7. doi: 10.1055/s-0032-1301896. Epub 2012 Feb 10.
